,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2017-08-24 02:26:00,The Zacks Research Daily presents the best research output of our analyst team.,0.6325156092643738,0.012341027148067951,0.35514333844184875,positive,0.6201745867729187
1,2017-08-24 02:26:00,"Today's Research Daily features new research reports on 16 major stocks, including TOTAL (TOT), Kimberly-Clark (KMB) and Salesforce (CRM).",0.03954626992344856,0.007327489089220762,0.9531262516975403,neutral,0.03221878036856651
2,2017-08-24 02:26:00,These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.,0.054846275597810745,0.007339245639741421,0.937814474105835,neutral,0.04750702902674675
3,2017-08-24 02:26:00,"You can see all of today's research reports here >>>

TOTAL shares have gained +7.5% over the last one year, outperforming the Zacks International Integrated Oil industry, which has gained +1.4% over the same period.",0.9558754563331604,0.025169964879751205,0.018954597413539886,positive,0.9307054877281189
4,2017-08-24 02:26:00,TOTAL's earnings missed expectations in the second-quarter.,0.022198021411895752,0.9670828580856323,0.010719075798988342,negative,-0.9448848366737366
5,2017-08-24 02:26:00,"However, it continues to benefit from new startups and acquisition, which is helping it boost production.",0.9524731040000916,0.017034724354743958,0.030492164194583893,positive,0.9354383945465088
6,2017-08-24 02:26:00,The Zacks analyst likes the company's commitment toward cost savings initiatives.,0.8493460416793823,0.015454455278813839,0.1351994425058365,positive,0.8338915705680847
7,2017-08-24 02:26:00,"After savings of $2.8 billion in 2016, TOTAL aims to save $3.5 billion this year.",0.8811150193214417,0.016513090580701828,0.10237191617488861,positive,0.8646019101142883
8,2017-08-24 02:26:00,"Going forward, the company will continue to benefit from upstream startups and cost management initiatives.",0.9274755120277405,0.013288589194417,0.05923596769571304,positive,0.9141868948936462
9,2017-08-24 02:26:00,The strategic acquisition of Maersk Oil will further strengthen its portfolio.,0.9503238201141357,0.015758197754621506,0.03391803056001663,positive,0.9345656037330627
10,2017-08-24 02:26:00,"However, fluctuating commodity prices, operations in some politically troubled regions and increasing competition could impact the company's profitability.",0.026759371161460876,0.8679343461990356,0.10530631244182587,negative,-0.8411749601364136
11,2017-08-24 02:26:00,(You can read the full research report on TOTAL here >>> ).,0.013149738311767578,0.014264434576034546,0.9725857973098755,neutral,-0.0011146962642669678
12,2017-08-24 02:26:00,"Shares of Kimberly-Clark have declined -7.8% over the last six months, underperforming the Zacks Consumer Staples industry, which has lost -5.6% over the same period.Kimberly-Clark posted dismal second quarter results, with both earnings and revenues lagging expectations.",0.019143152981996536,0.9707759618759155,0.010080811567604542,negative,-0.9516327977180481
13,2017-08-24 02:26:00,The company also anticipates soft earnings guidance for the full year.,0.0480150505900383,0.8682280778884888,0.08375683426856995,negative,-0.8202130198478699
14,2017-08-24 02:26:00,"The Zacks analyst likes the company's higher cost savings, continued product innovation and strong international presence.",0.9188916683197021,0.01368431095033884,0.0674239918589592,positive,0.9052073359489441
15,2017-08-24 02:26:00,"However, Kimberly-Clark has been witnessing slower organic sales growth, due to highly competitive promotional activity over several of the previous quarters.",0.027943039312958717,0.939773678779602,0.032283272594213486,negative,-0.9118306636810303
16,2017-08-24 02:26:00,"Also, Kimberly-Clark's second quarter earnings results were hampered by higher input cost inflation and lower sales due to softness in North America.",0.01888943649828434,0.9687716364860535,0.012338891625404358,negative,-0.9498822093009949
17,2017-08-24 02:26:00,A difficult economic environment in Latin America also remains a concern.,0.036899104714393616,0.29143211245536804,0.6716687679290771,neutral,-0.25453299283981323
18,2017-08-24 02:26:00,(You can read the full research report on Kimberly-Clark here >>> ).,0.01230003871023655,0.012393506243824959,0.9753064513206482,neutral,-9.346753358840942e-05
19,2017-08-24 02:26:00,"Buy-rated Salesforce shares have handily beat the broader Tech sector this year, with the stock up almost double the Zacks Technology sector's +17.4% gain in the year-to-date period.",0.9465152621269226,0.030420374125242233,0.023064404726028442,positive,0.9160948991775513
20,2017-08-24 02:26:00,Salesforce reported strong Q2 results with both top and bottom lines faring better than expectations.,0.9521803259849548,0.0297823715955019,0.01803719252347946,positive,0.9223979711532593
21,2017-08-24 02:26:00,"Additionally, there was marked significant year-over-year improvement and the company also provided a strong outlook.",0.9517167806625366,0.018010122701525688,0.0302730705589056,positive,0.9337066411972046
22,2017-08-24 02:26:00,The Zacks analyst likes the company's announcement of achieving $10 billion in sales in FY18.,0.8615260124206543,0.014363347552716732,0.12411058694124222,positive,0.847162663936615
23,2017-08-24 02:26:00,Salesforce's diverse cloud offerings and strong spending on digital marketing remain major catalysts.,0.8411522507667542,0.012066652067005634,0.14678111672401428,positive,0.8290855884552002
24,2017-08-24 02:26:00,"Additionally, strategic acquisitions and the resultant synergies are anticipated to prove conducive to growth over the long run.",0.9254710078239441,0.013231851160526276,0.0612972192466259,positive,0.912239134311676
25,2017-08-24 02:26:00,"Furthermore, last year's move to utilize Amazon data center's geographical reach to expand its international business is commendable.",0.9287963509559631,0.013608504086732864,0.0575951412320137,positive,0.9151878356933594
26,2017-08-24 02:26:00,(You can read the full research report on Salesforce here >>> ).,0.012213421985507011,0.013723894022405148,0.9740626215934753,neutral,-0.0015104720368981361
27,2017-08-24 02:26:00,"Other noteworthy reports we are featuring today include AutoZone (AZO), PVH Corp (PVH) and Fujifilm (FUJIY).",0.03637737035751343,0.005734247621148825,0.9578884243965149,neutral,0.030643122270703316
28,2017-08-24 02:26:00,"Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year.",0.9376703500747681,0.01678338833153248,0.045546285808086395,positive,0.9208869338035583
29,2017-08-24 02:26:00,"With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.",0.2419624775648117,0.023061107844114304,0.7349764108657837,neutral,0.2189013659954071
30,2017-08-24 02:26:00,This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing.,0.27703070640563965,0.009763316251337528,0.7132060527801514,neutral,0.2672673761844635
31,2017-08-24 02:26:00,You can apply it to your portfolio starting today.,0.03226230666041374,0.00492352107539773,0.9628141522407532,neutral,0.0273387860506773
32,2017-08-24 02:26:00,"Learn more >>

Note: SherazMian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings.",0.16852381825447083,0.007183871231973171,0.8242922425270081,neutral,0.16133995354175568
33,2017-08-24 02:26:00,He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trendsand Earnings Previewreports.,0.026142945513129234,0.011532393284142017,0.9623246192932129,neutral,0.014610552228987217
34,2017-08-24 02:26:00,"If you want an email notification each time Sheraz publishes a new article, please click here>>>

The Zacks analyst believes Kite Pharma's immuno-oncology candidate, axicabtagene ciloleucel will be approved this year.",0.594353199005127,0.010861319489777088,0.39478549361228943,positive,0.583491861820221
35,2017-08-24 02:26:00,"The Medicines Co.'s progress with its lead candidates, Inclisiran and Carbavance, is impressive.",0.9195384383201599,0.012505816295742989,0.06795569509267807,positive,0.9070326089859009
36,2017-08-24 02:26:00,"However, generic pressure on its lead drug Angiomax may hurt the top-line, believes the Zacks analyst.",0.024210186675190926,0.9587142467498779,0.01707543432712555,negative,-0.9345040321350098
37,2017-08-24 02:26:00,The Zacks analyst believes that the Petro-Canada Lubricants buy has helped HollyFrontier expand into a high-margin business but is concerned about Renewable Fuel Standard costs.,0.8654648661613464,0.030451593920588493,0.1040836051106453,positive,0.8350132703781128
38,2017-08-24 02:26:00,"The Zacks analyst believes that Teradyne's hard-disk drive (HDD) business will remain sluggish due to weakness in computing market, which is the main consumer of HDDs.",0.02586815506219864,0.8526403307914734,0.12149156630039215,negative,-0.826772153377533
39,2017-08-24 02:26:00,"Per the Zacks analyst, higher Class 8 truck production by the Commercial Truck & Industrial unit is aiding Meritor.",0.9456688165664673,0.022230690345168114,0.03210042417049408,positive,0.9234381318092346
40,2017-08-24 02:26:00,"North America, Europe and China are contributing most to this rise in production.",0.5340474247932434,0.011790808290243149,0.45416179299354553,positive,0.52225661277771
41,2017-08-24 02:26:00,The Zacks analyst thinks that robust sales of medical systems & imaging businesses would boost Fujifilm's near-term results.,0.9582408666610718,0.01971009187400341,0.022049030289053917,positive,0.9385308027267456
42,2017-08-24 02:26:00,The Zacks analyst believes that growing proved reserves of natural gas will aid Range Resources' production growth.,0.9431185126304626,0.014617797918617725,0.0422637052834034,positive,0.9285007119178772
43,2017-08-24 02:26:00,"Per the Zacks analyst, PVH Corp. witnessed solid momentum at its Calvin Klein and Tommy Hilfiger brands, particularly in the International regions.",0.9559865593910217,0.017649753019213676,0.02636372111737728,positive,0.9383367896080017
44,2017-08-24 02:26:00,This notably boosted sales in fiscal second-quarter.,0.9551560282707214,0.02074795961380005,0.02409605123102665,positive,0.9344080686569214
45,2017-08-24 02:26:00,"The covering analyst stresses that William-Sonoma is witnessing solid top-line growth courtesy of strategic initiatives, innovative marketing techniques, focus on innovation and retail optimization.",0.9473556876182556,0.014882279559969902,0.037762098014354706,positive,0.9324734210968018
46,2017-08-24 02:26:00,Luminex's Assay business is likely to be its key growth driver.,0.886452853679657,0.012026372365653515,0.10152077674865723,positive,0.8744264841079712
47,2017-08-24 02:26:00,The Zacks analyst is bullish on the recent CE-IVD mark for the ARIES Norovirus Assay and the FDA clearance of ARIES C. difficile Assay.,0.8032423853874207,0.03711511939764023,0.15964248776435852,positive,0.7661272883415222
48,2017-08-24 02:26:00,"The Zacks analyst is concerned with the company's high operating costs given its ongoing investments in many areas including trading platform, new protocols, infrastructure and headcount additions.",0.22271119058132172,0.1062069833278656,0.6710818409919739,neutral,0.11650420725345612
49,2017-08-24 02:26:00,"Per the Zacks analyst, a spate of store openings is raising costs for AutoZone.",0.9253309369087219,0.03932546451687813,0.03534360229969025,positive,0.8860054612159729
50,2017-08-24 02:26:00,This is not only adding to capital & operating expenses but also inventory per store.,0.04928930476307869,0.8583096861839294,0.09240102022886276,negative,-0.8090204000473022
51,2017-08-24 02:26:00,"Per the Zacks Analyst, AptarGroup's Beauty + Home segment may face headwinds in Brazil due to the tepid economy.",0.023180752992630005,0.957882821559906,0.018936479464173317,negative,-0.9347020387649536
52,2017-08-24 02:26:00,Business in China is at risk given the recent heat wave leading to energy restrictions.,0.021808821707963943,0.9435316920280457,0.03465940058231354,negative,-0.9217228889465332
53,2017-08-24 02:26:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
54,2017-08-24 02:26:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069372057914734,0.007019792217761278,0.9422864317893982,neutral,0.04367392882704735
55,2017-08-24 02:26:00,"Click to get this free report

To read this article on Zacks.com click here.",0.02068457007408142,0.033159855753183365,0.9461556077003479,neutral,-0.012475285679101944
56,2017-08-24 02:26:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
